These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Once versus thrice daily gentamicin in patients with serious infections. Prins JM; Büller HR; Kuijper EJ; Tange RA; Speelman P Lancet; 1993 Feb; 341(8841):335-9. PubMed ID: 8094114 [TBL] [Abstract][Full Text] [Related]
8. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity. Rostas SE; Kubiak DW; Calderwood MS Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573 [TBL] [Abstract][Full Text] [Related]
9. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects. Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733 [TBL] [Abstract][Full Text] [Related]
10. A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients. Marik PE; Lipman J; Kobilski S; Scribante J J Antimicrob Chemother; 1991 Nov; 28(5):753-64. PubMed ID: 1778878 [TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections. Blaser J; Simmen HP; Thurnheer U; König C; Lüthy R J Antimicrob Chemother; 1995 Nov; 36(5):803-14. PubMed ID: 8626261 [TBL] [Abstract][Full Text] [Related]
12. [Level of evidence for therapeutic drug monitoring of vancomycin]. Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM; Therapie; 2011; 66(1):29-37. PubMed ID: 21466775 [TBL] [Abstract][Full Text] [Related]
14. Top Guns: The "Maverick" and "Goose" of Empiric Therapy. Davies SW; Efird JT; Guidry CA; Dietch ZC; Willis RN; Shah PM; Sawyer RG Surg Infect (Larchmt); 2016 Feb; 17(1):38-47. PubMed ID: 26484854 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Burgess LD; Drew RH Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041 [TBL] [Abstract][Full Text] [Related]
16. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration. Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion. Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263 [TBL] [Abstract][Full Text] [Related]